Elefante Mark B Takes $5.30 Million Position in Proto Labs, Inc. $PRLB

Posted by Stanley Muller on Aug 24th, 2026

Elefante Mark B bought a new position in shares of Proto Labs, Inc. (NYSE:PRLB – Free Report) in the 2nd quarter, Holdings Channel reports. The fund bought 58,434 shares of the industrial products company’s stock, valued at approximately $5,302,000. Proto Labs makes up 2.3% of Elefante Mark B’s holdings, making the stock its 20th biggest position.

Other hedge funds and other institutional investors have also recently made changes to their positions in the company. Royal Bank of Canada increased its position in Proto Labs by 51.3% in the 1st quarter. Royal Bank of Canada now owns 6,510 shares of the industrial products company’s stock valued at $228,000 after acquiring an additional 2,207 shares during the period. AQR Capital Management LLC lifted its position in Proto Labs by 3.3% during the 1st quarter. AQR Capital Management LLC now owns 63,871 shares of the industrial products company’s stock worth $2,238,000 after acquiring an additional 2,040 shares during the period. NewEdge Advisors LLC lifted its position in Proto Labs by 7,380.0% during the 1st quarter. NewEdge Advisors LLC now owns 748 shares of the industrial products company’s stock worth $26,000 after acquiring an additional 738 shares during the period. JPMorgan Chase & Co. grew its stake in shares of Proto Labs by 68.8% in the 2nd quarter. JPMorgan Chase & Co. now owns 21,756 shares of the industrial products company’s stock valued at $871,000 after purchasing an additional 8,864 shares during the last quarter. Finally, Hsbc Holdings PLC purchased a new position in shares of Proto Labs in the 2nd quarter valued at approximately $480,000. Hedge funds and other institutional investors own 84.54% of the company’s stock.

Proto Labs Trading Down 0.2%

Shares of PRLB stock opened at $79.48 on Monday. The company has a market cap of $1.90 billion, a price-to-earnings ratio of 63.58 and a beta of 1.40. The stock has a 50 day simple moving average of $80.56 and a 200-day simple moving average of $70.31. Proto Labs, Inc. has a 12-month low of $45.10 and a 12-month high of $93.00.

Proto Labs (NYSE:PRLB – Get Free Report) last posted its quarterly earnings results on Friday, July 31st. The industrial products company reported $0.60 earnings per share for the quarter, beating analysts’ consensus estimates of $0.53 by $0.07. Proto Labs had a return on equity of 4.80% and a net margin of 5.44%.The firm had revenue of $149.34 million for the quarter, compared to the consensus estimate of $144.53 million. During the same period in the previous year, the business earned $0.41 earnings per share. The company’s revenue for the quarter was up 10.5% compared to the same quarter last year. Proto Labs has set its Q3 2026 guidance at 0.560-0.640 EPS. On average, equities analysts forecast that Proto Labs, Inc. will post 1.46 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

Several equities research analysts have recently commented on PRLB shares. Zacks Research upgraded Proto Labs from a “hold” rating to a “strong-buy” rating in a research note on Thursday, August 6th. Weiss Ratings lowered shares of Proto Labs from a “buy (b)” rating to a “buy (b-)” rating in a research report on Tuesday, August 18th. Wall Street Zen cut shares of Proto Labs from a “strong-buy” rating to a “buy” rating in a research note on Saturday, July 18th. Needham & Company LLC upgraded shares of Proto Labs from a “hold” rating to a “buy” rating and set a $87.00 price objective for the company in a research report on Monday, August 3rd. Finally, Benchmark raised their target price on shares of Proto Labs from $70.00 to $91.00 and gave the stock a “buy” rating in a research note on Thursday, July 2nd. One equities research analyst has rated the stock with a Strong Buy rating and three have given a Buy rating to the stock. According to MarketBeat.com, the company presently has an average rating of “Buy” and an average target price of $89.00.

Check Out Our Latest Analysis on PRLB

Insider Transactions at Proto Labs

In other Proto Labs news, Director Sven Wehrwein sold 2,000 shares of the firm’s stock in a transaction on Tuesday, June 2nd. The stock was sold at an average price of $77.28, for a total value of $154,560.00. Following the completion of the sale, the director owned 32,505 shares of the company’s stock, valued at approximately $2,511,986.40. This trade represents a 5.80% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Insiders own 1.30% of the company’s stock.

Proto Labs Company Profile

(Free Report)

Proto Labs, Inc is a digital manufacturing company that offers on-demand production services for custom parts and prototypes. Utilizing technologies such as 3D printing (additive manufacturing), CNC machining and injection molding, the company transforms digital CAD designs into functional parts on accelerated timelines. Its platform-driven process combines automated quoting, rapid tool generation and manufacturing execution to serve product developers, engineers and small- to medium-sized production runs.

Founded in 1999 by Larry Lukis, Proto Labs has championed the application of digital workflows to traditional manufacturing methods.